相关实验视频

Updated: May 28, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

贝尔祖提凡用于治疗细胞癌

Xiancheng Wu^1,2, David Lazris³, Risa Wong^4,5

¹Department of Medicine, Division of Hematology and Oncology, University of Washington/Fred Hutchinson Cancer Center, 1100 Fairview Avenue N - M1-B208, Seattle, WA 98109-1024, USA.

Therapeutic advances in medical oncology

|February 10, 2025

概括

贝尔祖提凡是第一种针对低氧诱导因子2α (HIF-2α) 的药物,有效治疗·希佩尔-林道氏病 (VHL) 和晚期细胞癌 (RCC). 临床试验表明它作为一线和组合疗法的有效性.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

·希佩尔-林道氏病 (VHL) 和零星的清细胞细胞癌 (ccRCC) 往往是由由于VHL基因变化的低氧诱导因子2α (HIF-2α) 过度表达引起的.
HIF-2α在ccRCC的瘤发生中发挥着关键作用,使其成为关键的治疗点.

研究的目的:

审查Belzutifan的开发和临床应用,这是一种新的HIF-2α抑制剂.
讨论贝尔祖提凡的疗效,安全性和正在进行的细胞癌治疗的研究.

主要方法:

对Belzutifan的FDA批准和临床试验数据的审查.
对贝尔祖提凡的作用机制的分析,针对HIF-2α.
检查安全数据,包括常见的副作用,如贫血.

主要成果:

贝尔祖提凡是FDA批准的第一个向HIF-2α的药物,最初用于VHL相关的RCC,后来用于先进的零星RCC.
临床试验证明了贝尔祖提凡作为单一疗法和组合疗法的活性.
贫血是一种常见的目标副作用,需要监测.

结论:

贝尔祖提凡通过向HIF-2α通路,代表了ccRCC治疗的重大进步.
目前正在进行的试验正在探索贝尔祖提凡在各种环境和组合中,以优化其使用.
未来的研究将专注于预测生物标志物和耐药性机制,以进一步完善治疗.

关键词:

这是VHLVHL.贝尔祖蒂芬是个很好的球员.缺氧诱导因子的诱导因子细胞癌瘤是细胞癌.系统性治疗系统性治疗

更多相关视频

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...